Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors

Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors

Background: Testicular germ cell tumors (TGCTs) are commonly diagnosed tumors in young men. However, a satisfactory approach to predict relapse of stage I TGCTs is still lacking. Therefore, this study aimed to develop a robust risk score model for stage I TGCTs.Method: RNA-sequence data of stage I T...

Full description

Bibliographic Details
Main Authors: Jian-Guo Zhou, Jie Yang, Su-Han Jin, Siyu Xiao, Lei Shi, Ting-You Zhang, Hu Ma, Udo S. Gaipl
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
testicular germ cell tumors
The Cancer Genome Atlas
risk score model
relapse
GEO
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01147/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01147/full

Similar Items